wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38201960-83B5C18E-5128-474F-9C86-833FA52FA9F1
Q38201960-83B5C18E-5128-474F-9C86-833FA52FA9F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38201960-83B5C18E-5128-474F-9C86-833FA52FA9F1
The ebbs and flows in the development of cholesterol-lowering drugs: prospects for the future.
P2860
Q38201960-83B5C18E-5128-474F-9C86-833FA52FA9F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38201960-83B5C18E-5128-474F-9C86-833FA52FA9F1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fe4b6920aadecba7b58783115db9dd98b48f972b
P2860
Effects of the new dual PPAR α/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism.